Platform Technology Partners Acquires 36,213 Shares of Axon Enterprise, Inc $AXON

Platform Technology Partners raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 5,478.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 36,874 shares of the biotechnology company’s stock after acquiring an additional 36,213 shares during the period. Axon Enterprise comprises about 2.4% of Platform Technology Partners’ investment portfolio, making the stock its 5th largest holding. Platform Technology Partners’ holdings in Axon Enterprise were worth $15,580,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the business. Keel Point LLC lifted its holdings in shares of Axon Enterprise by 4.4% during the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock valued at $254,000 after purchasing an additional 25 shares in the last quarter. Bridgewater Advisors Inc. raised its holdings in Axon Enterprise by 4.4% during the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock worth $352,000 after buying an additional 26 shares during the period. Pinnacle Wealth Planning Services Inc. raised its holdings in Axon Enterprise by 7.8% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 361 shares of the biotechnology company’s stock worth $153,000 after buying an additional 26 shares during the period. Roman Butler Fullerton & Co. raised its holdings in Axon Enterprise by 2.4% during the 1st quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock worth $500,000 after buying an additional 30 shares during the period. Finally, 44 Wealth Management LLC lifted its stake in Axon Enterprise by 6.0% in the first quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after buying an additional 30 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction on Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the sale, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 37,397 shares of company stock worth $21,234,034. Company insiders own 4.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on AXON shares. Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a report on Tuesday, October 27th. TD Cowen dropped their price objective on shares of Axon Enterprise from $825.00 to $800.00 and set a “buy” rating on the stock in a report on Monday, October 26th. Barclays boosted their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Argus upped their target price on shares of Axon Enterprise from $460.00 to $600.00 and gave the stock a “buy” rating in a research note on Thursday, September 3rd. Finally, UBS Group increased their target price on Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $688.38.

Axon Enterprise Trading Down 9.8%

NASDAQ AXON opened at $382.56 on Friday. The stock has a market capitalization of $31.08 billion, a price-to-earnings ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48. The stock’s 50 day moving average price is $447.49 and its two-hundred day moving average price is $476.73. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a 52 week low of $339.01 and a 52 week high of $665.07.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm had revenue of $908.55 million for the quarter, compared to analyst estimates of $934.33 million. During the same period last year, the company earned $1.17 EPS. The company’s revenue was up 27.8% compared to the same quarter last year. As a group, analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.